You are here

GenMark Diagnostics to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in two upcoming investor conferences.
Wednesday, February 20, 2019 - 16:55